Alpha 2.0
Login Register
» Articles » PMID: 10432915

Twenty-year Trends in the Reported Incidence of Mycosis Fungoides and Associated Mortality

Overview
Journal Am J Public Health
Specialty Public Health
Date 1999 Aug 5
PMID 10432915
Citations 35
Authors
M A Weinstock
B Gardstein
Affiliations
Soon will be listed here.
Abstract

Objectives: Patterns of mycosis fungoides incidence and associated mortality in the United States were evaluated.

Methods: Data were taken from the Surveillance, Epidemiology, and End Results cancer registry program and the National Center for Health Statistics.

Results: The incidence rate from 1973 through 1992 was 0.36/10(5) person-years. The age-adjusted incidence rate ratio of Blacks to Whites was 1.7; that of Asians to Whites was 0.6. There was no evidence of increasing incidence rates during the period 1983 through 1992. Mortality rates declined steadily from 1979 to 1991 and were less heterogeneous geographically than incidence rates. Mortality rate patterns with age, sex, and race were similar to the corresponding incidence patterns.

Conclusions: The incidence rate of mycosis fungoides has stabilized and the mortality rate has declined. For unknown reasons, the disorder varies greatly among demographic and geographic subgroups.

Citing Articles

Evaluation of Oxidative Stress by Thiol/Disulphide Homeostasis in Patients with Mycosis Fungoides: A Prospective Double-Centre Study.

Erduran F, Adisen E, Soyugur A, Eren F, Neselioglu S, Erel O Indian J Dermatol. 2024; 68(6):724.

PMID: 38371553 PMC: 10869007. DOI: 10.4103/ijd.ijd_339_23.

Significant survival disparity in Black patients with cutaneous lymphoma: a retrospective cohort study.

Trum N, Chen L, Zain J, Rosen S, Querfeld C Br J Dermatol. 2024; 190(6):916-917.

PMID: 38282350 PMC: 11099980. DOI: 10.1093/bjd/ljae039.

Racial Disparities in Mycosis Fungoides/Sézary Syndrome-A Single-Center Observational Study of 292 Patients.

Gandham A, Geller S, Dusza S, Kupper T, Myskowski P Clin Lymphoma Myeloma Leuk. 2024; 24(4):e174-e180.

PMID: 38245472 PMC: 10981557. DOI: 10.1016/j.clml.2023.12.017.

Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides.

Yu Z, Vieyra-Garcia P, Benezeder T, Crouch J, Kim I, OMalley J J Invest Dermatol. 2023; 144(3):621-632.e1.

PMID: 37716650 PMC: 10922223. DOI: 10.1016/j.jid.2023.06.212.

Effect of PUVA and NB-UVB Therapy on the Skin Cytokine Profile in Patients with Mycosis Fungoides.

Karamova A, Verbenko D, Vorontsova A, Zhilova M, Nikonorov A, Gatiatulina E J Oncol. 2022; 2022:3149293.

PMID: 35237320 PMC: 8885178. DOI: 10.1155/2022/3149293.

References
1.
Greene M, Dalager N, Lamberg S, Argyropoulos C, Fraumeni Jr J . Mycosis fungoides: epidemiologic observations. Cancer Treat Rep. 1979; 63(4):597-606. View
2.
Weinstock M, Horm J . Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. JAMA. 1988; 260(1):42-6. View
3.
Chuang T, Su W, Muller S . Incidence of cutaneous T cell lymphoma and other rare skin cancers in a defined population. J Am Acad Dermatol. 1990; 23(2 Pt 1):254-6. DOI: 10.1016/0190-9622(90)70208-y. View
4.
Karagas M, Thomas D, Roth G, Johnson L, Weiss N . The effects of changes in health care delivery on the reported incidence of cutaneous melanoma in western Washington State. Am J Epidemiol. 1991; 133(1):58-62. DOI: 10.1093/oxfordjournals.aje.a115802. View
5.
Weinstock M . Epidemiology of mycosis fungoides. Semin Dermatol. 1994; 13(3):154-9. View